Roadblocks at every turn: What reproductive health experts say about barriers to legislative abortion advocacy
This study examines the barriers experts in reproductive health experience to testifying at state legislative committee hearings regarding abortion. (Source: Contraception)
Source: Contraception - August 30, 2023 Category: OBGYN Authors: Emma Romell, Daniela Mansbach, Alisa Von Hagel Source Type: research
Changes in hair cortisol concentration in intrauterine device initiators: a prospective cohort study
Prior studies found increased hair cortisol concentration (a surrogate marker for hypothalamic pituitary adrenal axis activation) in users of the levonorgestrel intrauterine device (LNG 52mg IUD). We evaluated change in hair cortisol and psychometric tests in women initiating a copper (CuT380 IUD) or LNG 52mg IUD. (Source: Contraception)
Source: Contraception - August 24, 2023 Category: OBGYN Authors: Nora Doty, Ethan Beckley, Bharti Garg, Sumiko Maristany, David W. Erikson, Jeffrey T. Jensen Tags: Original Research Article Source Type: research
Postpartum contraceptive choice and fulfillment in patients with opioid use disorder
We examined the differences in postpartum contraception between patients with and without opioid use disorder (OUD). (Source: Contraception)
Source: Contraception - August 24, 2023 Category: OBGYN Authors: Kathryn THOMAS, Tani MALHOTRA, David NGENDAHIMANA, Kelly S GIBSON, Kavita Shah ARORA Tags: Brief Research Article Source Type: research
Access to care following Planned Parenthood ’s termination from Texas’ Medicaid network: A qualitative study
To explore Planned Parenthood Medicaid patients ’ experiences getting reproductive health care in Texas after the state terminated Planned Parenthood providers from its Medicaid program in 2021. (Source: Contraception)
Source: Contraception - August 17, 2023 Category: OBGYN Authors: Anna Chatillon, Elsa Vizcarra, Bhavik Kumar, Samuel L. Dickman, Anitra D. Beasley, Kari White Source Type: research
Recruiting pregnant people considering abortion: an analysis of differences in participant characteristics by recruitment site across online, abortion fund, and clinic-based sources
To evaluate differences by recruitment method in the characteristics of participants who are considering abortion. (Source: Contraception)
Source: Contraception - August 11, 2023 Category: OBGYN Authors: Heidi Moseson, Alexandra Wollum, Bria Goode, Caitlin McKenna, Tracey Wilkinson Source Type: research
Editorial Board
(Source: Contraception)
Source: Contraception - August 8, 2023 Category: OBGYN Source Type: research
Copyright info/Contents
(Source: Contraception)
Source: Contraception - August 8, 2023 Category: OBGYN Source Type: research
Contraceptive efficacy should primarily be measured using life table pregnancy rates
Contraceptive users have always deserved accurate and easy to understand information about the pregnancy risk associated with different contraceptive methods. After the recent Dobbs vs. Jackson decision in which the Supreme Court held that the right to privacy stipulation in the United States Constitution does not include abortion, reproductive health access and choices have become severely more limited [1,2]. Sexually active couples are urgently reevaluating their contraceptive options and now, more than ever, deserve the most accurate and understandable information on how well methods work. (Source: Contraception)
Source: Contraception - August 8, 2023 Category: OBGYN Authors: Christine K Mauck, Clint Dart, Andrea Thurman, Mitchell D Creinin Tags: Commentary Source Type: research
Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial
To evaluate the feasibility and effectiveness of providing bedside family planning services to women with chronic medical conditions in the inpatient setting. (Source: Contraception)
Source: Contraception - August 5, 2023 Category: OBGYN Authors: Ryan Spielvogel, Rebecca B. Stephens, Robert Clark, Michele Guillen, Andrea Hankins, Carol Parise Source Type: research
Characteristics of people obtaining medication vs procedural abortions in clinical settings in the United States: Findings from the 2021 –2022 Abortion Patient Survey
This study aimed to compare the characteristics of people obtaining medication and procedural abortions in clinical settings in the United States. (Source: Contraception)
Source: Contraception - August 4, 2023 Category: OBGYN Authors: Rachel K. Jones, Doris W. Chiu, Julia E. Kohn Source Type: research
Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month supply of contraception
This study aimed to characterize awareness of a 2017 Massachusetts (MA) law that ensures access to a 12-month supply of short-acting contraceptive methods (e.g., pill, patch, and vaginal ring) among short-acting contraceptive users in MA and to identify perceived benefits and concerns of a 12-month supply. (Source: Contraception)
Source: Contraception - August 4, 2023 Category: OBGYN Authors: Neena T. Qasba, Kate F. Wallace, Veronica Yu, Kam L. Capoccia, Sarah L. Goff, Natalia Shcherbakova Source Type: research
Characteristics of people obtaining medication versus procedural abortions in clinical settings in the United States: Findings from the 2021 –2022 Abortion Patient Survey
To compare the characteristics of people obtaining medication and procedural abortions in clinical settings in the United States. (Source: Contraception)
Source: Contraception - August 4, 2023 Category: OBGYN Authors: Rachel K. Jones, Doris W. Chiu, Julia E. Kohn Source Type: research
Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month-supply of contraception
To characterize awareness of a 2017 Massachusetts (MA) law that ensures access to a 12-month supply of short-acting contraceptive methods (e.g., pill, patch, vaginal ring) among short-acting contraceptive users in MA and to identify perceived benefits and concerns of a 12-month-supply. (Source: Contraception)
Source: Contraception - August 4, 2023 Category: OBGYN Authors: Neena T. Qasba, Kate F. Wallace, Veronica Yu, Kam L. Capoccia, Sarah L. Goff, Natalia Shcherbakova Source Type: research
The efficacy, safety, and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
This study aimed to compare contraceptive efficacy and safety of drospirenone 4 mg in a 24/4-day regimen in nonobese and obese users and describe pharmacokinetics according to bodyweight. (Source: Contraception)
Source: Contraception - August 3, 2023 Category: OBGYN Authors: Mitchell D. Creinin, Alicyoy Angulo, Enrico Colli, David F. Archer Tags: Original Research Article Source Type: research
The efficacy, safety and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users
To compare contraceptive efficacy and safety of drospirenone 4 mg in a 24/4-day regimen in non-obese and obese users and describe pharmacokinetics according to bodyweight. (Source: Contraception)
Source: Contraception - August 3, 2023 Category: OBGYN Authors: Mitchell D. Creinin, Alicyoy Angulo, Enrico Colli, David F. Archer Tags: Original Research Article Source Type: research
